mdlinx mdlinx
Oncology Articles on MDLinx Top Read Articles
of 2012
Print

The value of 3.0Tesla diffusion-weighted MRI for pelvic nodal staging in patients with early stage cervical cancer
European Journal of Cancer, 07/30/2012

Klerkx WM et al. – Diffusion–weighted magnetic resonance imaging (MRI) did not result in additional diagnostic value compared to conventional MRI.

Methods
  • 68 federation internationale de gynecologie obstetrique (FIGO) stage Ia2 to IIb cervical cancer patients were included.
  • Sensitivity and specificity rates for two experienced observers were computed for the detection of lymphatic metastasis.
  • Reproducibility of conventional MRI was tested by kappa statistics.
  • The variables included in the analysis were: size of the long axis, short axis, ratio short to long axis and apparent diffusion coefficient (ADC).

Results
  • Nine patients had 15 positive pelvic nodes at histopathological examination.
  • The sensitivity and specificity of lymphatic metastasis detection by predefined conventional MRI characteristics was 33% (95% Confidence Interval (CI) 3–64) and 83% (95% CI 74–93) on patient level, and 33% (95% CI 7–60) and 97% (95% CI 95–99) on regional level respectively for observer 1.
  • For observer 2 the sensitivity was 33% (95% CI 3–64) and the specificity 93% (95% CI 87–100) on patient level, and 25% (95% CI 1–50) and 98% (95% CI 97–100) on regional level, respectively.
  • The kappa-value for reproducibility of metastasis detection on regional level was 0.50.
  • The short axis diameter showed the highest diagnostic accuracy (area under the curve (AUC)=0.81 95% CI 0.70–0.91); ADC did not improve diagnostic accuracy (AUC=0.83 95% CI 0.73–0.93).

Get reports via email to claim your reading activity at MDLinx as Category 2 CME (It takes less than a minute)

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow Us
Facebook

Receive free subspecialty
"5-minute updates" via email

Sign up!

Send the E-mail Newsletter to a Colleague


Send

Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More

Close